EXPLORATION OF THE IMMUNOGENETIC LANDSCAPE OF HYPERPROGRESSIVE DISEASE AFTER COMBINED IMMUNOTHERAPY IN CANCER PATIENTS

Exploration of the immunogenetic landscape of hyperprogressive disease after combined immunotherapy in cancer patients

Summary: The immune-genetic changes that occur in fireface ufx iii cancer patients experiencing hyperprogressive disease (HPD) during combined immunotherapy are unclear.In this study, HPD patients with pre- and post-HPD samples and non-HPD patients with solid tumors were molecularly characterized by genetic and tumor immune microenvironment (TiME)

read more



Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy

Abstract Solid tumors are complex entities that actively shape their microenvironment to create a supportive environment for their own caneta clareadora dental growth.Angiogenesis and immune suppression are two key characteristics of this tumor microenvironment.Despite attempts to deplete tumor blood vessels using antiangiogenic drugs, extensive ve

read more